[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582347":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":29,"centralContacts":33,"locations":39,"responsibleParty":86,"collaborators":89,"id":95,"slug":96,"hasResults":97,"nctId":98,"briefTitle":99,"officialTitle":100,"acronym":101,"eligibilityCriteria":102,"healthyVolunteers":97,"sex":103,"minAge":104,"maxAge":105,"enrollmentInfo":106,"targetDuration":37,"studyType":109,"phases":110,"briefSummary":112,"conditions":113,"keywords":116,"overallStatus":42,"whyStopped":37,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":128,"locationsCount":129},{"fullName":5,"class":6},"Linkoeping University","OTHER_GOV",[8,14],{"label":9,"type":10,"description":9,"interventionNames":11},"OGTT at the clinic then at home","EXPERIMENTAL",[12,13],"Diagnostic Test: OGTT at home using CGM","Diagnostic Test: OGTT at the clinic",{"label":15,"type":10,"description":15,"interventionNames":16},"OGTT at home then at the clinic",[12,13],[18,24],{"type":19,"name":20,"description":20,"armGroupLabels":21,"otherNames":22},"DIAGNOSTIC_TEST","OGTT at home using CGM",[15,9],[23],"OGTT-home",{"type":19,"name":25,"description":25,"armGroupLabels":26,"otherNames":27},"OGTT at the clinic",[15,9],[28],"OGTT-clinic",[30],{"name":31,"affiliation":5,"role":32},"Peder af Geijerstam, MD, PhD","PRINCIPAL_INVESTIGATOR",[34],{"name":31,"role":35,"phone":36,"phoneExt":37,"email":38},"CONTACT","+46739597426",null,"peder.af.geijerstam@liu.se",[40,59,71],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Primary Health Care Center Bra Liv Rosenhälsan","RECRUITING","Huskvarna","Jönköping County","55185","Sweden","SE",{"type":49,"coordinates":50},"Point",[51,52],14.30214,57.78596,{"lat":52,"lon":51},[55],{"name":56,"role":35,"phone":57,"phoneExt":37,"email":58},"Maria Samefors, MD, PhD","+46102423550","maria.samefors@liu.se",{"facility":60,"status":42,"city":61,"state":61,"zip":62,"country":46,"countryCode":47,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"Primary Health Care Center Cityhälsan Centrum","Norrköping","60239",{"type":49,"coordinates":64},[65,66],16.1826,58.59419,{"lat":66,"lon":65},[69],{"name":31,"role":35,"phone":70,"phoneExt":37,"email":38},"+46101059140",{"facility":72,"status":42,"city":73,"state":74,"zip":75,"country":46,"countryCode":47,"cosmosGeoPoint":76,"geoPoint":80,"contacts":81},"Primary Care Center Vårdcentralen Kärna","Linköping","Östergötland County","58662",{"type":49,"coordinates":77},[78,79],15.62157,58.41086,{"lat":79,"lon":78},[82],{"name":83,"role":35,"phone":84,"phoneExt":37,"email":85},"Karin Rådholm, MD, PhD","+4613281756","karin.radholm@liu.se",{"type":32,"investigatorFullName":87,"investigatorTitle":88,"investigatorAffiliation":5,"oldNameTitle":37,"oldOrganization":37},"Peder af Geijerstam","Principal Investigator",[90,92],{"name":91,"class":6},"Region Jönköping County",{"name":93,"class":94},"Region Östergötland","OTHER","100582347","ogtt-at-home-using-cgm-vs-at-the-clinic-100582347",false,"NCT06862128","OGTT at Home Using CGM vs at the Clinic","Oral Glucose Tolerance Test at Home With Continuous Glucose Monitoring vs Standard Clinic-based Testing","OGTT-CGM","Inclusion Criteria:\n\n* Prediabetes indicated by ≥2 of the following values, measured at separate occasions or through different analyses during the past 2 years:\n* \\- Fasting venous plasma glucose ≥6.1 but ≤6.9 mmol\u002FL\n* \\- Non-fasting venous plasma glucose ≥7.8 but ≤11.0 mmol\u002FL\n* \\- HbA1c ≥39 but ≤47 mmol\u002Fmol\n* Access to a smart phone which is compatible with the CGM application and has working Bluetooth connectivity\n* Ability to read and respond to online instructions and questionnaires in Swedish.\n\nExclusion Criteria:\n\n* T2D indicated by ≥2 of the following values, measured at different occasions or through different analyses:\n* \\- Fasting venous plasma glucose ≥7.0 mmol\u002FL\n* \\- Non-fasting venous plasma glucose value ≥11.1 mmol\u002FL\n* \\- HbA1c ≥48 mmol\u002Fmol\n* Previous bariatric surgery e.g., gastric by-pass or gastric sleeve surgery\n* Body mass index \\\u003C20 kg\u002Fm2\n* Body weight \\\u003C43 kg\n* Current pregnancy\n* Need of regular use of GLP-1 receptor agonists, SGLT-2 inhibitors, acetaminophen or ascorbic acid supplements during the study period\n* Fear of needle sticks\n* Shift work during the study period\n* Involvement in the study design, data collection, analysis, or participant recruitment.","ALL","18 Years","70 Years",{"count":107,"type":108},75,"ESTIMATED","INTERVENTIONAL",[111],"NA","This randomized, crossover study evaluates the feasibility and accuracy of a self-administered oral glucose tolerance test (OGTT) at home using continuous glucose monitoring (CGM) compared to a standard clinic-based OGTT. Participants with prediabetes will undergo both home-based and clinic-based OGTTs, with glucose levels measured via CGM and venous plasma glucose. The primary outcome is the correlation between CGM-based glucose values and standard OGTT results. Secondary outcomes include diagnostic agreement, metabolic hormone associations, and feasibility of home-based testing as a diagnostic tool for dysglycemia.",[114,115],"Pre-diabetes","Diabetes",[114,115,117,118,119],"Oral glucose tolerance test","Continuous glucose monitoring","Glucose","2026-05-15",{"date":122,"type":123},"2026-05-19","ACTUAL",{"date":125,"type":123},"2025-06-11",{"date":127,"type":108},"2040-12-31",{"name":5,"class":6},3]